Refreshing results…
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Download from www.nature.comRobust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
UploadPALB2 variant status in hematological malignancies – a potential therapeutic target?
UploadUnique features and clinical importance of acute alloreactive immune responses
Download from doi.orgPerturbation of the normal immune system in patients with CLL
Download from www.bloodjournal.orgMissing publications? Search for publications with a matching author name.